NOVO NORDISK INC. for NOVO NORDISK INC.

Health Issues HCR

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012 on National Diabetes Prevention Program; CMS Obesity Intervention; Healthy People 2020 Abstract; CMS CLIA Program & HIPAA Privacy Rule Patient Access to Test Reports; AHRQ regarding the USPSTF recommendation on screening and management of obesity in adults; PCORI Draft Research Agenda

Contacted: White House Office; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; Natl Institutes of Health (NIH); Labor, Dept of (DOL); Food & Drug Administration (FDA)

Bills named: S. 1559 (112th), H.R. 2954 (112th), H.R. 2960 (112th)

Medicare/Medicaid MMM

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Issues related to Medicaid rebates and similar revenue provisions as contained in P.L. 112-25, Budget Control Act of 2011 (deficit reduction); HR 3743 Middle Class Tax Relief and Job Creation Act of 2011, HR 3630 Middle Class Tax Relief and Job Creation Act of 2011, and HR 3765 (PL 112-78) Temporary Payroll Tax Cut Continuation of 2011-Issues related to Medicaid rebates and similar revenue provisions; Medicaid coverage of obesity counseling and expanding provider type.

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL)

Bills named: H.R. 3630 (112th), H.R. 2741 (112th), H.R. 3743 (112th), H.R. 3765 (112th)

Budget/Appropriations BUD

FY12 Budget Resolution and FY13 Appropriations: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation and National Diabetes Prevention Program HR 2608 (PL 112-36) Continuing Appropriations Act, 2012; HJ RES 94 (PL 112-67); CR through 12/17/11; HJ RES 95 (PL 112-68) CR through 12/23/11; P.L. 112-74 Consolidated Appropriations Act of 2012 on National Diabetes Prevention Program

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); White House Office; Centers For Disease Control & Prevention (CDC); SENATE; Labor, Dept of (DOL)

Bills named: H.R. 2608 (112th), H.J.Res. 95 (112th), H.J.Res. 94 (112th)

Pharmacy PHA

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; Supply Chain safety; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Labor, Dept of (DOL); Executive Office of the President (EOP); White House Office

Bills named: H.R. 2112 (112th)

Taxation/Internal Revenue Code TAX

H.R. 436 Protect Medical Innovation Act of 2011

Contacted: White House Office; Natl Institutes of Health (NIH); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 436 (112th)

Law Enforcement/Crime/Criminal Justice LAW

S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); White House Office; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH)

Bills named: S. 1002 (112th), H.R. 4223 (112th)